COVID-19 Conversations Podcast: Participation in vaccine trial

UC dean for clinical research discusses his decision to participate, need for diversity in science

In November 2020, less than a year after SARS-CoV-2, the virus that causes COVID-19, was identified, the world received optimistic news about several vaccines that showed efficacy in fighting the disease. The world is now watching in excitement as the first COVID-19 vaccines are being administered in the United Kingdom and the U.S.

Researchers and scientists often receive accolades and awards when research is successful, but although the attention is well-deserved, the essential role of research participants, without whom none of the successes would be possible, should also be recognized and celebrated.

In the podcast series COVID-19 Conversations, hosts talk to three COVID-19 vaccine trial participants, including Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine and chief of research services at UC Health.

Brett Kissela, MD, Senior Associate Dean for Clinical Research, patient in the Moderna Vaccine trial.  Gary Frazier, UC Health, blood drawl and Covid testing.

Brett Kissela, MD, has his blood drawn as part of the clinical trial process. Photo/Colleen Kelley/UC Creative + Brand

In September, Kissela became a participant in the Moderna trial at the university.

In this podcast of the African Alliance, based in South Africa, Kissela discusses why he chose to particpate, his experiences, hopes and fears as well as what he wants others, globally, to know about the research process.  

Listen to the podcast.

Featured photo of Brett Kissela participating in the Moderna vaccine trial by Colleen Kelley. 

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

1

What's ahead during Trump's second term

December 13, 2024

President-elect Donald Trump wants to give broad oversight of the health care sector to Robert F. Kennedy Jr., selecting him to head the Department of Health and Human Services. Kennedy is a vaccine skeptic. On Cincinnati Edition, Carl Fichtenbaum, MD, discussed some of the priorities floated in the new administration when it comes to health care.

2

Millions of kids in Africa are likely suffering from asthma...

December 13, 2024

A study shows that one in eight children in several African countries have asthma, and the vast majority are undiagnosed and therefore untreated. Tesfaye Mersha, PhD, studies asthma at the University of Cincinnati College of Medicine. He says the disease has been a growing issue in Africa during the last three decades, and it's linked to climate change and lifestyle changes.

Debug Query for this